NEJM Publishes Shionogi Phase 3 SCORPIO-PEP Study Showing Ensitrelvir Significantly Reduces COVID-19 Risk After Exposure Shionogi & Co., Ltd. announced that results from its global Phase 3 clinical trial, SCORPIO-PEP, evaluating the investigational oral antiviral ensitrelvir for post-exposure prophylaxis (PEP)…
Cord for Life® Completes Historic Phase 1 Clinical Trial Exploring Cord Blood Stem Cell Therapy for Lower Back Pain Cord for Life®has announced the successful completion of Phase 1 enrollment and dosing in a groundbreaking clinical trial investigating the use…
Dana-Farber to Expand Advanced Cancer Care with Installation of Mevion’s Compact Proton Therapy System The landscape of cancer treatment continues to evolve as healthcare providers increasingly adopt advanced technologies designed to improve patient outcomes while minimizing treatment-related side effects. In…
Health Executives Partner to Create Pioneering Women’s Health AI Initiative The women’s health industry is entering a transformative new era with the launch of the Women’s Health AI Consortium, a groundbreaking initiative created to establish the first clinically rigorous and…
STAAR Surgical Reports Strong First Quarter 2026 Results With Record Sales and Return to Profitability STAAR Surgical Company reported record first quarter 2026 financial results, highlighting significant revenue growth, improved profitability, and continued momentum for its EVO family of Implantable…
HeartBeam Reports Strong First Quarter 2026 Progress as Commercial Expansion and AI-Driven Cardiac Innovation Accelerate HeartBeam, a medical technology company focused on transforming cardiac care through advanced ECG-based solutions, reported financial and operational results for the first quarter ended March…
Turn Therapeutics Publishes First Quarter 2026 Results Alongside Company Updates Turn Therapeutics a clinical-stage biotechnology company focused on developing targeted inflammatory and immunological therapies for dermatologic diseases, has reported its financial results for the first quarter ended March 31, 2026,…
HealthWarehouse.com Reports First Quarter 2026 Financial Results Amid Strategic Shift Toward Technology and AI Partnerships HealthWarehouse.com,a U.S.-based healthcare e-commerce and digital pharmacy company, has reported its financial results for the first quarter ended March 31, 2026. The company also outlined…
NYU Langone and PEP Expand School-Based Overdose Prevention Initiative with Support from Anthem Foundation NYU Langone Family Health Centers (FHC) and NYU Langone’s Prevention Education Partnership (PEP) are advancing a major school-based initiative aimed at preventing and responding to opioid…
Virginia Strengthens Foster Care Support System During National Foster Care Month Through New Training and Partnership Initiatives As Virginia observes National Foster Care Month this May, state leaders, healthcare partners, and community organizations are coming together to strengthen the support…
Novanta Reports Strong First Quarter 2026 Results with Double-Digit Revenue Growth and Rising Bookings Novanta a trusted technology partner for medical and advanced technology equipment manufacturers, announced its financial results for the first quarter of 2026, highlighting strong revenue growth,…
Firefly Health Delivers More Than 15% in Total Cost of Care Savings for ASO Population Firefly Health, a clinically integrated health plan redefining the way healthcare is financed and delivered, has announced significant financial and clinical performance outcomes across its…